Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: twentyfirstcenturyfox who wrote (11922)	1/24/2003 1:25:54 AM
From: axial	Read Replies (1) \| Respond to of 14101

Fox, my apologies for the late response; the more so because I was so eagerly awaiting your posts. "Can you or anyone post: - is there a new IR person; - does that mean that Renny Ho is gone? - if yes to either, does anyone have an email address?" The best summary I've seen of the CC was by Cal Gary, here: Message 18468410 As far as I know, Rennie Ho is still with DMX. Hope that helps. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ WRT your research in Thailand, excellent! I realize that its a slog, and I'm sure everyone appreciates the effort. "...there has been a test under way in Canada for the past 2 years, under the SAP program of HC. I can find absolutely zilch, about it, on the HC SAP site. Am I the only one who was unaware of this?" Fox, I think a lot of people were unaware of this; I know I was. I don't know of anyone besides Greg Pugen that is treating people with WF10, so I assume that the SAP data relates to his patients. It doesn't appear to be a "trial" in the accepted sense, but rather a collection of data on his patients, whose treatments have been for a wide range of conditions. The Thai info was somewhat disappointing, in that it was so limited. I never got any further response from the mystery SH poster, "supposedly" using WF10 off-label in Thailand. We'll have to chalk it up as bogus, I guess. "There have been safety studies completed here, but the main one is yet to be announced. It is referenced as <the WF10-98-THAI-01CYS study>." I suspect the study will confirm what we already know: the safety of WF10 is well-established. The story is that Oxo Chemie and DMX have sought to keep WF10 "under wraps" - until the time is right. Judging by the CC, the right time is fast approaching. Given all the difficulty that DMX has had with the P3 data, I simply don't believe they would have struggled this far, if the data was equivocal. I recognize the legitimate warnings to be cautious - but I believe efficacy is established. The question was in the acceptability of the data. The fact that DMX has struggled to get the data to the FDA - and is in the process of doing so - makes me believe we have a winner. Why? Because if the data was doubtful, I think DMX would simply have dropped the matter - as many others have done, with inconclusive P3 data. That's just an inference, an opinion: time will tell. Thanks again for your efforts. Jim